Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Nov;102(2):268–273. doi: 10.1111/j.1365-2249.1995.tb03776.x

Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation.

J P Christensen 1, J Johansen 1, O Marker 1, A R Thomsen 1
PMCID: PMC1553417  PMID: 7586677

Abstract

The effect of systemic virus infection on the level of circulating ICAM-1 (cICAM-1) in serum, and the role of virus-activated T cells in this context, were studied using the murine lymphocytic choriomeningitis virus infection as primary model system. A marked virus-induced elevation in cICAM-1 in serum was revealed, the presence of which coincided with the phase of virus-induced T cell activation. However, high levels of cICAM-1 in serum were observed well before maximal T cell activation could be demonstrated. No increase in cICAM-1 was observed in the serum of infected T cell-deficient nude mice, clearly demonstrating that T cells were mandatory. Analysis of MHC class I and MHC class II-deficient mice revealed that either CD4+ or CD8+ T cells alone are sufficient, despite a markedly reduced inflammatory exudate in the former animals. These results indicate that virus-activated T cells induce shedding of ICAM-1 into the circulation, and this parameter may be used as an early and sensitive marker for immune activation.

Full text

PDF
268

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. H., Mainolfi E., Burra P., Neuberger J. M., Ayres R., Elias E., Rothlein R. Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology. 1992 Sep;16(3):810–814. doi: 10.1002/hep.1840160330. [DOI] [PubMed] [Google Scholar]
  2. Allan J. E., Dixon J. E., Doherty P. C. Nature of the inflammatory process in the central nervous system of mice infected with lymphocytic choriomeningitis virus. Curr Top Microbiol Immunol. 1987;134:131–143. doi: 10.1007/978-3-642-71726-0_6. [DOI] [PubMed] [Google Scholar]
  3. Andersson E. C., Christensen J. P., Marker O., Thomsen A. R. Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J Immunol. 1994 Feb 1;152(3):1237–1245. [PubMed] [Google Scholar]
  4. Andersson E. C., Christensen J. P., Scheynius A., Marker O., Thomsen A. R. Lymphocytic choriomeningitis virus infection is associated with long-standing perturbation of LFA-1 expression on CD8+ T cells. Scand J Immunol. 1995 Jul;42(1):110–118. doi: 10.1111/j.1365-3083.1995.tb03633.x. [DOI] [PubMed] [Google Scholar]
  5. Becker J. C., Dummer R., Hartmann A. A., Burg G., Schmidt R. E. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol. 1991 Dec 15;147(12):4398–4401. [PubMed] [Google Scholar]
  6. Christensen J. P., Andersson E. C., Scheynius A., Marker O., Thomsen A. R. Alpha 4 integrin directs virus-activated CD8+ T cells to sites of infection. J Immunol. 1995 May 15;154(10):5293–5301. [PubMed] [Google Scholar]
  7. Christensen J. P., Marker O., Thomsen A. R. T-cell responsiveness to LCMV segregates as a single locus in crosses between BALB/cA and C.B-17 mice. Evidence for regulation by a gene outside the Igh region. Scand J Immunol. 1993 Sep;38(3):215–224. doi: 10.1111/j.1365-3083.1993.tb01717.x. [DOI] [PubMed] [Google Scholar]
  8. Christensen J. P., Marker O., Thomsen A. R. The role of CD4+ T cells in cell-mediated immunity to LCMV: studies in MHC class I and class II deficient mice. Scand J Immunol. 1994 Oct;40(4):373–382. doi: 10.1111/j.1365-3083.1994.tb03477.x. [DOI] [PubMed] [Google Scholar]
  9. Cosgrove D., Gray D., Dierich A., Kaufman J., Lemeur M., Benoist C., Mathis D. Mice lacking MHC class II molecules. Cell. 1991 Sep 6;66(5):1051–1066. doi: 10.1016/0092-8674(91)90448-8. [DOI] [PubMed] [Google Scholar]
  10. Dustin M. L., Rothlein R., Bhan A. K., Dinarello C. A., Springer T. A. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol. 1986 Jul 1;137(1):245–254. [PubMed] [Google Scholar]
  11. Gearing A. J., Newman W. Circulating adhesion molecules in disease. Immunol Today. 1993 Oct;14(10):506–512. doi: 10.1016/0167-5699(93)90267-O. [DOI] [PubMed] [Google Scholar]
  12. Grusby M. J., Johnson R. S., Papaioannou V. E., Glimcher L. H. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science. 1991 Sep 20;253(5026):1417–1420. doi: 10.1126/science.1910207. [DOI] [PubMed] [Google Scholar]
  13. Hamann A., Rebstock S. Migration of activated lymphocytes. Curr Top Microbiol Immunol. 1993;184:109–124. doi: 10.1007/978-3-642-78253-4_9. [DOI] [PubMed] [Google Scholar]
  14. Hviid L., Theander T. G., Elhassan I. M., Jensen J. B. Increased plasma levels of soluble ICAM-1 and ELAM-1 (E-selectin) during acute Plasmodium falciparum malaria. Immunol Lett. 1993 Apr;36(1):51–58. doi: 10.1016/0165-2478(93)90068-d. [DOI] [PubMed] [Google Scholar]
  15. Issekutz T. B. Lymphocyte homing to sites of inflammation. Curr Opin Immunol. 1992 Jun;4(3):287–293. doi: 10.1016/0952-7915(92)90078-s. [DOI] [PubMed] [Google Scholar]
  16. Jander S., Heidenreich F., Stoll G. Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases. Neurology. 1993 Sep;43(9):1809–1813. doi: 10.1212/wnl.43.9.1809. [DOI] [PubMed] [Google Scholar]
  17. Marker O., Volkert M. Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice. J Exp Med. 1973 Jun 1;137(6):1511–1525. doi: 10.1084/jem.137.6.1511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mason J. C., Kapahi P., Haskard D. O. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum. 1993 Apr;36(4):519–527. doi: 10.1002/art.1780360412. [DOI] [PubMed] [Google Scholar]
  19. Nielsen H. V., Christensen J. P., Andersson E. C., Marker O., Thomsen A. R. Expression of type 3 complement receptor on activated CD8+ T cells facilitates homing to inflammatory sites. J Immunol. 1994 Sep 1;153(5):2021–2028. [PubMed] [Google Scholar]
  20. Pfau C. J., Valenti J. K., Pevear D. C., Hunt K. D. Lymphocytic choriomeningitis virus killer T cells are lethal only in weakly disseminated murine infections. J Exp Med. 1982 Jul 1;156(1):79–89. doi: 10.1084/jem.156.1.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pober J. S., Gimbrone M. A., Jr, Lapierre L. A., Mendrick D. L., Fiers W., Rothlein R., Springer T. A. Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol. 1986 Sep 15;137(6):1893–1896. [PubMed] [Google Scholar]
  22. Rothlein R., Czajkowski M., O'Neill M. M., Marlin S. D., Mainolfi E., Merluzzi V. J. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J Immunol. 1988 Sep 1;141(5):1665–1669. [PubMed] [Google Scholar]
  23. Rothlein R., Mainolfi E. A., Czajkowski M., Marlin S. D. A form of circulating ICAM-1 in human serum. J Immunol. 1991 Dec 1;147(11):3788–3793. [PubMed] [Google Scholar]
  24. Schattner A., Meshorer A., Wallach D. Involvement of interferon in virus-induced lymphopenia. Cell Immunol. 1983 Jul 1;79(1):11–25. doi: 10.1016/0008-8749(83)90046-1. [DOI] [PubMed] [Google Scholar]
  25. Shijubo N., Imai K., Aoki S., Hirasawa M., Sugawara H., Koba H., Tsujisaki M., Sugiyama T., Hinoda Y., Yachi A. Circulating intercellular adhesion molecule-1 (ICAM-1) antigen in sera of patients with idiopathic pulmonary fibrosis. Clin Exp Immunol. 1992 Jul;89(1):58–62. doi: 10.1111/j.1365-2249.1992.tb06877.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Springer T. A. Adhesion receptors of the immune system. Nature. 1990 Aug 2;346(6283):425–434. doi: 10.1038/346425a0. [DOI] [PubMed] [Google Scholar]
  27. Young L. H., Klavinskis L. S., Oldstone M. B., Young J. D. In vivo expression of perforin by CD8+ lymphocytes during an acute viral infection. J Exp Med. 1989 Jun 1;169(6):2159–2171. doi: 10.1084/jem.169.6.2159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zijlstra M., Bix M., Simister N. E., Loring J. M., Raulet D. H., Jaenisch R. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature. 1990 Apr 19;344(6268):742–746. doi: 10.1038/344742a0. [DOI] [PubMed] [Google Scholar]
  29. Zinkernagel R. M., Althage A., Holland J. Target antigens for H-2-restricted vesicular stomatitis virus-specific cytotoxic T cells. J Immunol. 1978 Aug;121(2):744–748. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES